» Articles » PMID: 27104047

Classification of Laser Vaccine Adjuvants

Overview
Date 2016 Apr 23
PMID 27104047
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

An immunologic adjuvant, which enhances the magnitude and quality of immune responses to vaccine antigens, has become an essential part of modern vaccine practice. Chemicals and biologicals have been typically used for this purpose, but there are an increasing number of studies that are being conducted on the vaccine adjuvant effect of laser light on the skin. Currently, four different types or classes of laser devices have been shown to systemically enhance immune responses to intradermal vaccination: ultra-short pulsed lasers, non-pulsed lasers, non-ablative fractional lasers and ablative fractional lasers. Aside from involving the application of laser light to the skin in a manner that minimizes discomfort and damage, each type of laser vaccine adjuvant involves emission parameters, modes of action and immunologic adjuvant effects that are quite distinct from each other. This review provides a summary of the four major classes of "laser vaccine adjuvant" and clarifies and resolves their characteristics as immunologic adjuvants. These aspects of each adjuvant's properties will ultimately help define which laser would be most efficacious in delivering a specific clinical benefit with a specific vaccine.

Citing Articles

Photobiomodulation and nitric oxide signaling.

Kashiwagi S, Morita A, Yokomizo S, Ogawa E, Komai E, Huang P Nitric Oxide. 2022; 130:58-68.

PMID: 36462596 PMC: 9808891. DOI: 10.1016/j.niox.2022.11.005.


Dual near-infrared II laser modulates the cellular redox state of T cells and augments the efficacy of cancer immunotherapy.

Katagiri W, Yokomizo S, Ishizuka T, Yamashita K, Kopp T, Roessing M FASEB J. 2022; 36(10):e22521.

PMID: 36052742 PMC: 9574655. DOI: 10.1096/fj.202200033R.


Near-infrared II photobiomodulation augments nitric oxide bioavailability via phosphorylation of endothelial nitric oxide synthase.

Yokomizo S, Roessing M, Morita A, Kopp T, Ogawa E, Katagiri W FASEB J. 2022; 36(9):e22490.

PMID: 35929438 PMC: 9382775. DOI: 10.1096/fj.202101890R.


Brief exposure of skin to near-infrared laser augments early vaccine responses.

Yokomizo S, Katagiri W, Maki Y, Sano T, Inoue K, Fukushi M Nanophotonics. 2021; 10(12):3187-3197.

PMID: 34868804 PMC: 8635068. DOI: 10.1515/nanoph-2021-0133.


Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects.

Hettinga J, Carlisle R Vaccines (Basel). 2020; 8(3).

PMID: 32947966 PMC: 7564253. DOI: 10.3390/vaccines8030534.


References
1.
Bergmann-Leitner E, Leitner W . Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators. Vaccines (Basel). 2015; 2(2):252-96. PMC: 4494256. DOI: 10.3390/vaccines2020252. View

2.
Hu J, Mathias-Santos C, Greene C, King-Lyons N, Rodrigues J, Hajishengallis G . Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen. PLoS One. 2014; 9(12):e113978. PMC: 4275187. DOI: 10.1371/journal.pone.0113978. View

3.
Rappuoli R, Mandl C, Black S, De Gregorio E . Vaccines for the twenty-first century society. Nat Rev Immunol. 2011; 11(12):865-72. PMC: 7098427. DOI: 10.1038/nri3085. View

4.
Wang J, Li B, Wu M . Effective and lesion-free cutaneous influenza vaccination. Proc Natl Acad Sci U S A. 2015; 112(16):5005-10. PMC: 4413338. DOI: 10.1073/pnas.1500408112. View

5.
Chen X, Pravetoni M, Bhayana B, Pentel P, Wu M . High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants. Vaccine. 2012; 31(1):159-64. PMC: 3557791. DOI: 10.1016/j.vaccine.2012.10.069. View